老年成人帕金森病
Parkinson disease in the elderly adult.
作者信息
Willis Allison W
机构信息
Movement Disorders Division, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, USA.
出版信息
Mo Med. 2013 Sep-Oct;110(5):406-10.
Abstract
Parkinson disease is the second most neurodegenerative disease, after Alzheimer disease, that affects up to two million Americans, the overwhelming majority of whom are aged 60 and older. The changing demographics of the country place more Americans at risk for Parkinson disease (PD) than ever before. Primary care physicians treat the majority of PD patients in the United States. Here I review diagnosis and treatment strategies for idiopathic Parkinson disease in the elderly adult.
摘要
帕金森病是仅次于阿尔茨海默病的第二大神经退行性疾病，影响多达200万美国人，其中绝大多数年龄在60岁及以上。该国不断变化的人口结构使更多美国人面临患帕金森病（PD）的风险，比以往任何时候都多。在美国，大多数帕金森病患者由初级保健医生治疗。在此，我将回顾老年成人特发性帕金森病的诊断和治疗策略。
相似文献
1
Parkinson disease in the elderly adult.
Mo Med. 2013 Sep-Oct;110(5):406-10.
2
Parkinson disease: research update and clinical management.
South Med J. 2012 Dec;105(12):650-6. doi: 10.1097/SMJ.0b013e318273a60d.
3
The current and projected economic burden of Parkinson's disease in the United States.
Mov Disord. 2013 Mar;28(3):311-8. doi: 10.1002/mds.25292. Epub 2013 Feb 21.
4
Associations between cerebrovascular risk factors and parkinson disease.
Ann Neurol. 2019 Oct;86(4):572-581. doi: 10.1002/ana.25564. Epub 2019 Aug 29.
5
Predictors of survival in patients with Parkinson disease.
Arch Neurol. 2012 May;69(5):601-7. doi: 10.1001/archneurol.2011.2370.
6
Time Trends in the Incidence of Parkinson Disease.
JAMA Neurol. 2016 Aug 1;73(8):981-9. doi: 10.1001/jamaneurol.2016.0947.
7
Incidence and remaining lifetime risk of Parkinson disease in advanced age.
Neurology. 2009 Feb 3;72(5):432-8. doi: 10.1212/01.wnl.0000341769.50075.bb.
8
Prevalence of Parkinson disease among the Navajo: a preliminary examination.
J Parkinsons Dis. 2013;3(2):193-8. doi: 10.3233/JPD-120158.
9
Parkinson's disease revisited.
J Neurosci Nurs. 2000 Aug;32(4):216-21.
10
Parkinson disease with and without Dementia: A prevalence study and future projections.
Mov Disord. 2018 Apr;33(4):537-543. doi: 10.1002/mds.27277. Epub 2018 Jan 22.
引用本文的文献
1
Oleanolic acid activates the JNK-Sp1-DJ-1 axis to promote mitophagy-mediated neuroprotection in dopaminergic neurons for Parkinson's disease treatment.
Arch Pharm Res. 2025 Jun 19. doi: 10.1007/s12272-025-01550-4.
2
Case Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease.
Int J Mol Sci. 2024 Aug 2;25(15):8447. doi: 10.3390/ijms25158447.
3
Aerobic exercise improves motor dysfunction in Parkinson's model mice via differential regulation of striatal medium spiny neuron.
Sci Rep. 2024 May 27;14(1):12132. doi: 10.1038/s41598-024-63045-4.
4
Visual Dysfunction and Occupational Performance in Persons With Parkinson's Disease.
Am J Occup Ther. 2023 Nov 1;77(6). doi: 10.5014/ajot.2023.050235.
5
Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
Int J Mol Sci. 2023 Apr 13;24(8):7205. doi: 10.3390/ijms24087205.
6
Quantification of Movement Error from Spiral Drawing Test.
Sensors (Basel). 2023 Mar 11;23(6):3043. doi: 10.3390/s23063043.
7
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.
J Parkinsons Dis. 2023;13(2):145-164. doi: 10.3233/JPD-223517.
8
Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling.
NPJ Parkinsons Dis. 2022 Apr 22;8(1):49. doi: 10.1038/s41531-022-00315-w.
9
Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality.
J Parkinsons Dis. 2022;12(2):545-556. doi: 10.3233/JPD-212834.
10
Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson's Disease May Be Related to its Anti-Inflammatory Action.
Molecules. 2020 Nov 9;25(21):5206. doi: 10.3390/molecules25215206.
本文引用的文献
1
Prospective cohort study of impulse control disorders in Parkinson's disease.
Mov Disord. 2013 Mar;28(3):327-33. doi: 10.1002/mds.25291. Epub 2013 Jan 2.
2
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.
JAMA Neurol. 2013 Feb;70(2):183-90. doi: 10.1001/jamaneurol.2013.646.
3
A case control study of women with Parkinson's disease and their fertility characteristics.
J Neurol Sci. 2012 Aug 15;319(1-2):135-8. doi: 10.1016/j.jns.2012.05.026. Epub 2012 May 28.
4
Tai chi for patients with Parkinson's disease.
N Engl J Med. 2012 May 3;366(18):1737; author reply 1738. doi: 10.1056/NEJMc1202921.
5
Tai chi and postural stability in patients with Parkinson's disease.
N Engl J Med. 2012 Feb 9;366(6):511-9. doi: 10.1056/NEJMoa1107911.
6
Predictors of survival in patients with Parkinson disease.
Arch Neurol. 2012 May;69(5):601-7. doi: 10.1001/archneurol.2011.2370.
7
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.
J Neurol. 2012 Mar;259(3):462-8. doi: 10.1007/s00415-011-6202-y. Epub 2011 Aug 5.
8
Parkinson's disease risk from ambient exposure to pesticides.
Eur J Epidemiol. 2011 Jul;26(7):547-55. doi: 10.1007/s10654-011-9574-5. Epub 2011 Apr 20.
9
LRRK2 variation and Parkinson's disease in African Americans.
Mov Disord. 2010 Sep 15;25(12):1973-6. doi: 10.1002/mds.23163.
10
Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.
Neuroepidemiology. 2010;34(3):143-51. doi: 10.1159/000275491. Epub 2010 Jan 15.
Zotero 插件